An investigator-blinded evaluation of fluocinonide 0.1% cream in the treatment of atopic dermatitis and psoriasis vulgaris

Cosmetic Dermatology

Volumn 20, Issue 9, 2007, Pages 545-552

  Del Rosso, James Q ^a,b,c   Conte, Eugene T ^d,e  

^a UNIVERSITY OF NEVADA   (United States)

^b TOURO UNIVERSITY NEVADA   (United States)

^c VALLEY HOSPITAL MEDICAL CENTER   (United States)

^d Advanced Dermatology of Ohio   (United States)

^e OHIO UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOCINONIDE; TACROLIMUS;

ADULT; AGED; ATOPIC DERMATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PSORIASIS VULGARIS; REVIEW; RISK ASSESSMENT; SINGLE BLIND PROCEDURE; SKIN DISEASE;

EID: 35348887695     PISSN: 10413766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (1)

1. Vanos (fluocinonide) cream 0.1% [package insert]. Scottsdale, Ariz: Medicis Pharmaceutical Corporation; 2006.